Dr. Walter G. Copan – Congressional Testimony: The State of U.S. Science and Technology: Ensuring U.S. Global Leadership

On February 5th, 2025, Dr. Walter G. Copan testified before the House Committee on Science, Space, and Technology on the State of U.S. Science and Technology: Ensuring U.S. Global Leadership.

Copan, Vice President for Research and Technology Transfer at the Colorado School of Mines, former Director of the National Institute of Standards and Technology (NIST), and CSIS Senior Adviser, emphasized the crucial role of investment in public-sector R&D, as well as STEM education and workforce training.

“Two decades ago, the United States was the undisputed global leader in science and technology, and in driving innovation for economic value creation. Today, however, by many internationally recognized measures, America’s global leadership position in the majority of the critical technology fields has been overtaken by China.”

“We are in a period where crisis presents America with great opportunity. The U.S. must take a new strategic approach to the future of research and S&T advancement that engages across government agencies. We must leverage collaboration and investments with the private sector, bolster education at all levels, and engage with our national R&D, intellectual property, standards and innovation enterprise. We have the chance to drive great synergies in federal R&D investment, through a national S&T and innovation strategy.”

Watch the full hearing here, and read Dr. Copan’s opening remarks here.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More